ArticleFrontiers in oncology2020

Matrix Metallopeptidase 14: A Candidate Prognostic Biomarker for Diffuse Large B-Cell Lymphoma.

Chengliang Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.